Physician profile
Michael J Katich
NPI 1669449765
$1,443.28
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $24.04 · 2021: $224 · 2022: $263 · 2023: $315 · 2024: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $455.69 | 2019-2024 | Cvi Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Allergan, INC. | $243.51 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $206.93 | 2023-2024 | Infuse, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $170.61 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $127.09 | 2019-2021 | |
| Lkc Technologies, INC. | $71.52 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $61.92 | 2022 | |
| Alcon Vision LLC | $37.73 | 2024 | Total30 |
| Astellas Pharma US INC | $27.37 | 2024 | Izervay |
| Novartis Pharmaceuticals Corporation | $22.64 | 2021 | |
| Aerie Pharmaceuticals, INC. | $18.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Katich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.